FDA Moves to Pull Controversial Preterm Birth Drug From the Market
(MedPage Today) — The FDA is calling for withdrawal of the approval for the injectable agent 17α-hydroxyprogesterone caproate (17-OHPC; Makena) for pregnant women with a history of at least one…